Oct 10 2013
KFx Medical Corporation announced that a jury in the United States District Court for the Southern District of California awarded KFx $29 million in its patent infringement case against Arthrex. The jury found that Arthrex willfully infringed the KFx patents by promoting its SutureBridge and SpeedBridge rotator-cuff repair procedures. The jury also upheld the validity of KFx's patents.
KFx filed a complaint against Arthrex on August 1, 2011, alleging claims of induced and contributory infringement of United States Patent Number 7,585,311 ("the '311 Patent"), and later amended the complaint to add related patents.
"We are thankful to the judge, jury, and our attorneys at Knobbe Martens with lead counsel Joe Jennings for their hard and diligent work," said Tate Scott, president and CEO of KFx. "The protection of patented innovations allows KFx to continue its research and development into products and technology that enhance patient care."
On August 13, 2013, KFx announced that it had entered into an agreement licensing the '311 and related patents, which are used in knotless double row rotator cuff repair. Hundreds of thousands of arthroscopic rotator cuff repairs in the United States utilize the technique to achieve an anatomic reattachment of tendon to bone.